(Total Views: 721)
Posted On: 11/24/2020 6:16:28 PM
Post# of 155038
Re: Shelly2626 #66515
Mel, on the Yahoo Message board wrote this 2 hours ago.
Ocoimmune's drug, like Remdesivir, is an IV administered drug. It shows promise but is very complex to make, so ramping up production will be a major challenge. Unlikely to have any doses ready until mid-2021. They stated they won't be making an EUA request until they can produce. At 50% clinically improved, it's promising but still less promising than Leronlimab and Aviptadil in my opinion.
Ocoimmune's drug, like Remdesivir, is an IV administered drug. It shows promise but is very complex to make, so ramping up production will be a major challenge. Unlikely to have any doses ready until mid-2021. They stated they won't be making an EUA request until they can produce. At 50% clinically improved, it's promising but still less promising than Leronlimab and Aviptadil in my opinion.
(3)
(0)
